| Endoscopy 1997; 29:235-240. [CrossRef] [Medline] | |
| 2. | Svoboda P, Kantorova I, Ochmann J, et al. A prospective randomized controlled trial of sclerotherapy vs. ligation in the prophylactic treatment of high-risk esophageal varices. Surg Endosc 1999; 13:580-584. |
| 3. | Gotoh Y, Iwakiri R, Sakata Y, et al. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: a prospective, controlled trial compared with endoscopic injection sclerotherapy. J Gastroenterol Hepatol 1999; 14:241-244. [Medline] |
| 4. | Sarin SK, Lahoti D, Sacena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16:1343-1349. [CrossRef] [Medline] |
| 5. | Trudenau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986; 32:264-268. [CrossRef][Medline] |
| 6. | Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 1995; 27:349-354. [CrossRef] [Medline] |
| 7. | Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33:1060-1064. [CrossRef] [Medline] |
| 8. | Miyazaki S, Yoshida T, Harada T, et al. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate.Hepatogastroenterology 1998; 45:1155-1158. [Medline] |
| 9. | Ogawa K, Ishikawa S, Naritaka Y, et al. Clinical evaluation of endoscopic injection sclerotherapy using N-butyl-2-cyanoacrylate for gastric variceal bleeding. |